NMPA Approval

Nimustine Hydrochloride for Injection

Approval Number

国药准字H20058694

Company吉斯美（武汉）制药有限公司

Registration Date

March 3, 2022

Previous Approval Numbers

国药准字H20058694

Drug Information

Generic Name

注射用盐酸尼莫司汀

Dosage Form

注射剂

Strength

50mg

Drug Type

化学药品

Registration Date

March 3, 2022

Company Information

Applicant Company

Company Name吉斯美（武汉）制药有限公司

Company Address

武汉东湖新技术开发区高新大道858号生物医药园

Manufacturing Company

Company Name吉斯美（武汉）制药有限公司

Company Address

湖北省武汉市东湖新技术开发区关南工业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸尼莫司汀 - NMPA 批准文号 | MedPath